Compass Pathways
Clinical trials sponsored by Compass Pathways, explained in plain language.
-
Magic mushroom compound takes on depression in major trial
Symptom relief OngoingThis study tests a drug called COMP360 (a form of psilocybin, the active ingredient in magic mushrooms) in people with depression that hasn't improved with other treatments. About 572 adults will receive either a high or low dose, and researchers will measure changes in mood and …
Phase: PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Magic mushroom compound takes on tough depression in major trial
Symptom relief OngoingThis phase 3 trial tests whether a single dose of COMP360 psilocybin, given under supportive conditions, can safely reduce depression symptoms in 255 adults with treatment-resistant depression. Participants are randomly assigned to receive either the drug or a placebo, and their …
Phase: PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC